[HTML][HTML] Autoimmune liver diseases in systemic rheumatic diseases

CR Wang, HW Tsai - World journal of gastroenterology, 2022 - ncbi.nlm.nih.gov
Systemic rheumatic diseases (SRDs) are chronic, inflammatory, autoimmune disorders with
the presence of autoantibodies that may affect any organ or system. Liver dysfunction in …

[HTML][HTML] Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies

PJ Trivedi, CL Bowlus, KK Yimam, H Razavi… - Clinical Gastroenterology …, 2022 - Elsevier
Background & Aims The aim of this study was to quantify the global epidemiology of primary
sclerosing cholangitis (PSC), alongside the incidence of liver transplantation, cancer, and …

[HTML][HTML] Greater transplant-free survival in patients receiving obeticholic acid for primary biliary cholangitis in a clinical trial setting compared to real-world external …

CFM Perez, H Fisher, S Hiu, D Kareithi, F Adekunle… - Gastroenterology, 2022 - Elsevier
Background & Aims The Primary Biliary Cholangitis (PBC) Obeticholic Acid (OCA)
International Study of Efficacy (POISE) randomized, double-blind, placebo-controlled trial …

Autoimmune hepatitis: Challenges and novelties

I Olivas, S Rodriguez-Tajes, MC Londoño - Medicina Clínica (English …, 2022 - Elsevier
Autoimmune hepatitis is a chronic inflammatory disease of the liver. The etiology is partly
unknown and commonly affects women of all ages. It is characterised by increase in …

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

A Miah, G Tinoco, S Zhao, L Wei, A Johns… - Journal of Cancer …, 2022 - Springer
Abstract Purpose Immune checkpoint inhibitors (ICIs) are associated with a unique set of
immune-related adverse events (irAEs). Few studies have evaluated the risk factors and …

[HTML][HTML] Endothelin receptor B enhances liver injury and pro-inflammatory responses by increasing G-protein-coupled receptor kinase-2 expression in primary biliary …

G Xu, Y Gong, F Lu, B Wang, Z Yang, L Chen, J Min… - Scientific Reports, 2022 - nature.com
Severe diseases like cirrhosis and liver failure can be developed from primary biliary
cholangitis (PBC). Endothelin-2 (EDN2) and endothelin receptor B (EDNRB) are related to …

Rare liver diseases are not rare in China

T Lv, J Jia - Liver International, 2022 - Wiley Online Library
Rare diseases, also known as orphan diseases, are a group of diseases that affect a
relatively small number of people. Low incidence rates, atypical symptoms, imperfect …

Diagnosis and management of autoimmune hepatitis

L Muratori, AW Lohse, M Lenzi - bmj, 2023 - bmj.com
Autoimmune hepatitis is an inflammatory disease of the liver of unknown cause that may
progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment …

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

J Ampuero, A Lucena, M Hernández-Guerra… - Gut, 2022 - gut.bmj.com
We read with interest the work by Mansoor et al 1 regarding the outcomes of COVID-19 in
coeliac disease. The impact of pre-existing chronic liver diseases on COVID-19 outcomes …

[HTML][HTML] zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis

X Li, Y Zhang, J Wang, Y Li, Y Wang, F Shi, L Hong… - Journal of …, 2022 - Elsevier
Background & aims Autoimmune hepatitis (AIH) is characterized by hepatocyte destruction,
leading to lymphocyte and macrophage accumulation in the liver. Macrophages are key …